Analyst Price Target is $5.00
▲ +518.05% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Rubius Therapeutics in the last 3 months. The average price target is $5.00, with a high forecast of $8.00 and a low forecast of $3.00. The average price target represents a 518.05% upside from the last price of $0.81.
Current Consensus is
The current consensus among 4 contributing investment analysts is to buy stock in Rubius Therapeutics. This rating has held steady since March 2022, when it changed from a Hold consensus rating.